Developments in therapies for AML - chemotherapy, targeted therapy and immunotherapy
Hagop M. Kantarjian
Big data on efficacy and toxicity levels for ibrutinib in CLL
Working towards a cure for multiple myeloma
Brian Walker et al.
The important issues to consider when deciding when a multiple myeloma patient must start treatment
BCR inhibitors improving CLL patient outcomes